Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2011 (2011), Article ID 561909, 13 pages
http://dx.doi.org/10.1155/2011/561909
Review Article

Treatment of Acute Pelvic Inflammatory Disease

Department of Obstetrics and Gynecology, University of California, Davis, CA 95817, USA

Received 19 July 2011; Accepted 13 September 2011

Academic Editor: Thomas Cherpes

Copyright © 2011 Richard L. Sweet. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Workowski and S. Berman, “Sexually transmitted diseases treatment guidelines,” Morbidity and Mortality Weekly Report, vol. 59, no. 12 RR, pp. 63–67, 2010. View at Google Scholar
  2. J. Ross, P. Judlin, and L. Nilas, “European guideline for the management of pelvic inflammatory disease,” International Journal of STD and AIDS, vol. 18, no. 10, pp. 662–666, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. L. Sweet, “Microbiology,” in Pelvic Inflammatory Disease, R. L. Sweet and H. C. Wiesenfeld, Eds., pp. 19–48, Taylor & Francis, London, UK, 2006. View at Google Scholar
  4. C. L. Haggerty and R. B. Ness, “Diagnosis and treatment of pelvic inflammatory disease,” Women's Health, vol. 4, no. 4, pp. 383–397, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. K. J. Smith, R. B. Ness, H. C. Wiesenfeld, and M. S. Roberts, “Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies,” Sexually Transmitted Diseases, vol. 34, no. 12, pp. 960–966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Y. Sutton, M. Sternberg, A. Zaidi, M. E. S. Louis, and L. E. Markowitz, “Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001,” Sexually Transmitted Diseases, vol. 32, no. 12, pp. 778–784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. D. B. Rein, W. J. Kassler, K. L. Irwin, and L. Rabiee, “Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial,” Obstetrics and Gynecology, vol. 95, no. 3, pp. 397–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Botte and J. F. Peipert, “Epidemiology,” in Pelvic Inflammatory Disease, R. L. Sweet and H. C. Wiesenfeld, Eds., pp. 1–18, Taylor & Francis, London, UK, 2006. View at Google Scholar
  9. C. L. Haggerty and R. B. Ness, “Epidemiology, pathogenesis and treatment of pelvic inflammatory disease,” Expert Review of Anti-Infective Therapy, vol. 4, no. 2, pp. 235–247, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. L. Westrom, “Effect of acute pelvic inflammatory disease on fertility,” American Journal of Obstetrics and Gynecology, vol. 121, no. 5, pp. 707–713, 1975. View at Google Scholar · View at Scopus
  11. L. Westrom, R. Joesoef, G. Reynolds, A. Hagdu, and S. E. Thompson, “Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results,” Sexually Transmitted Diseases, vol. 19, no. 4, pp. 185–192, 1992. View at Google Scholar
  12. C. L. Haggerty, R. Schulz, and R. B. Ness, “Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease,” Obstetrics and Gynecology, vol. 102, no. 5, pp. 934–939, 2003. View at Publisher · View at Google Scholar
  13. A. R. Thurman and D. E. Soper, “Sequelae,” in Pelvic Inflammatory Disease, R. L. Sweet and H. C. Wiesenfeld, Eds., pp. 69–84, Taylor & Francis, London, UK, 2006. View at Google Scholar
  14. H. C. Wiesenfeld, S. L. Hillier, M. A. Krohn et al., “Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease,” Obstetrics and Gynecology, vol. 100, no. 3, pp. 456–463, 2002. View at Publisher · View at Google Scholar
  15. P. Wolner-Hanssen, N. B. Kiviat, and K. K. Holmes, “Atypical pelvic inflammatory disease: subacute, chronic or subclinical upper genital tract infection in women,” in Sexually Transmitted Diseases, K. K. Holmes, P.-A. Mardh, and P. F. Sparling, Eds., pp. 615–620, McGraw–Hill, New York, NY, USA, 1990. View at Google Scholar
  16. L. Westrom and D. A. Eschenbach, “Pelvic inflammatory disease,” in Sexually Transmitted Diseases, K. K. Holmes, P. F. Sparling, P.-A. Mardh et al., Eds., pp. 783–809, McGraw–Hill, New York, NY, USA, 1999. View at Google Scholar
  17. C. K. Walker and H. C. Wiesenfeld, “Antibiotic therapy for acute pelvic inflammatory disease: the 2006 centers for disease control and prevention sexually transmitted diseases treatment guidelines,” Clinical Infectious Diseases, vol. 44, no. 3, pp. S111–S122, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. C. L. Haggerty and R. B. Ness, “Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials,” Clinical Infectious Diseases, vol. 44, no. 7, pp. 953–960, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. A. W. Chow, K. L. Malkasian, J. R Marshall et al., “The bacteriology of acute pelvic inflammatory disease. Value of cul de sac cultures and relative importance of gonococci and other aerobic or anaerobic bacteria,” American Journal of Obstetrics and Gynecology, vol. 122, no. 7, pp. 876–879, 1975. View at Google Scholar · View at Scopus
  20. D. A. Eschenbach, T. M. Buchanan, and H. M. Pollock, “Polymicrobial etiology of acute pelvic inflammatory disease,” New England Journal of Medicine, vol. 293, no. 4, pp. 166–171, 1975. View at Google Scholar · View at Scopus
  21. G. R. G. Monif, S. L. Welkos, H. Baer, and R. J. Thompson, “Cul de sac isolates from patients with endometritis salpingitis peritonitis and gonococcal endocervicitis,” American Journal of Obstetrics and Gynecology, vol. 126, no. 2, pp. 158–161, 1976. View at Google Scholar · View at Scopus
  22. F. G. Cunningham, J. C. Hauth, and L. C. Gilstrap, “The bacterial pathogenesis of acute pelvic inflammatory disease,” Obstetrics and Gynecology, vol. 52, no. 2, pp. 161–164, 1978. View at Google Scholar
  23. R. L. Sweet, D. L. Draper, and J. Schachter, “Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample?” American Journal of Obstetrics and Gynecology, vol. 138, no. 7, pp. 985–989, 1980. View at Google Scholar · View at Scopus
  24. S. E. Thompson 3rd, W. D. Hager, and K. H. Wong, “The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients,” American Journal of Obstetrics and Gynecology, vol. 136, no. 2, pp. 179–186, 1980. View at Google Scholar · View at Scopus
  25. R. L. Sweet, “Sexually transmitted diseases. Pelvic inflammatory disease and infertility in women,” Infectious Disease Clinics of North America, vol. 1, no. 1, pp. 199–215, 1987. View at Google Scholar · View at Scopus
  26. R. L. Sweet, J. Schachter, and M. O. Robbie, “Failure of β-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis,” Journal of the American Medical Association, vol. 250, no. 19, pp. 2641–2645, 1983. View at Publisher · View at Google Scholar · View at Scopus
  27. R. L. Sweet, J. Schachter, D. V. Landers, M. Ohm-Smith, and M. O. Robbie, “Treatment of hopitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline,” American Journal of Obstetrics and Gynecology, vol. 158, no. 3, supplement, pp. 736–743, 1988. View at Google Scholar
  28. D. V. Landers, P. Wolner-Hanssen, J. Paavonen et al., “Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease,” American Journal of Obstetrics and Gynecology, vol. 164, no. 3, pp. 849–858, 1991. View at Google Scholar · View at Scopus
  29. J. N. Wasserheit, T. A. Bell, and N. B. Kiviat, “Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin,” Annals of Internal Medicine, vol. 104, no. 2, pp. 187–193, 1986. View at Google Scholar · View at Scopus
  30. P. K. Heinonen, K. Teisala, and R. Punnonen, “Anatomic sites of upper genital tract infection,” Obstetrics and Gynecology, vol. 66, no. 3, pp. 384–390, 1985. View at Google Scholar · View at Scopus
  31. J. Paavonen, K. Teisala, and P. K. Heinonen, “Microbiological and histopathological findings in acute pelvic inflammatory disease,” British Journal of Obstetrics and Gynaecology, vol. 94, no. 5, pp. 454–460, 1987. View at Google Scholar · View at Scopus
  32. R. C. Brunham, B. Binns, F. Guijon et al., “Etiology and outcome of acute pelvic inflammatory disease,” Journal of Infectious Diseases, vol. 158, no. 3, pp. 510–517, 1988. View at Google Scholar · View at Scopus
  33. D. E. Soper, N. J. Brockwell, H. P. Dalton, and D. Johnson, “Observations concerning the microbial etiology of acute salpingitis,” American Journal of Obstetrics and Gynecology, vol. 170, no. 4, pp. 1008–1017, 1994. View at Google Scholar · View at Scopus
  34. S. L. Hillier, N. B. Kiviat, S. E. Hawes et al., “Role of bacterial vaginosis-associated microorganisms in endometritis,” American Journal of Obstetrics and Gynecology, vol. 175, no. 2, pp. 435–441, 1996. View at Google Scholar · View at Scopus
  35. C. L. Haggerty, S. L. Hillier, D. C. Bass, and R. B. Ness, “Bacterial vaginosis and anaerobic bacteria are associated with endometritis,” Clinical Infectious Diseases, vol. 39, no. 7, pp. 990–995, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. C. R. Cohen, L. E. Manhart, E. A. Bukusi et al., “Association between Mycoplasma genitalium and acute endometritis,” The Lancet, vol. 359, no. 9308, pp. 765–766, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. I. Simms, K. Eastick, H. Mallinson et al., “Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease,” Journal of Clinical Pathology, vol. 56, no. 8, pp. 616–618, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. C. R. Cohen, N. R. Mugo, S. G. Astete et al., “Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis,” Sexually Transmitted Infections, vol. 81, no. 6, pp. 463–466, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. H. F. Svenstrup, J. Fedder, S. E. Kristoffersen, B. Trolle, S. Birkelund, and G. Christiansen, “Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility-a prospective study,” Fertility and Sterility, vol. 90, no. 3, pp. 513–520, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. C. L. Haggerty, P. A. Totten, S. G. Astete et al., “Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease,” Sexually Transmitted Infections, vol. 84, no. 5, pp. 338–342, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. V. L. Short, P. A. Totten, R. B. Ness, S. G. Astete, S. F. Kelsey, and C. L. Haggerty, “Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease,” Clinical Infectious Diseases, vol. 48, no. 1, pp. 41–47, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. R. B. Ness, D. E. Soper, R. L. Holley et al., “Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (PEACH) randomized trial,” American Journal of Obstetrics and Gynecology, vol. 186, no. 5, pp. 929–937, 2002. View at Google Scholar · View at Scopus
  43. R. B. Ness, S. L. Hillier, K. E. Kip et al., “Bacterial vaginosis and risk of pelvic inflammatory disease,” Obstetrics and Gynecology, vol. 104, no. 4, pp. 761–769, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. D. E. Soper, N. J. Brockwell, H. P. Dalton, and D. Johnson, “Observations concerning the microbial etiology of acute salpingitis,” American Journal of Obstetrics and Gynecology, vol. 170, no. 4, pp. 1008–1017, 1994. View at Google Scholar · View at Scopus
  45. S. L. Hillier, N. B. Kiviat, S. E. Hawes et al., “Role of bacterial vaginosis-associated microorganisms in endometritis,” American Journal of Obstetrics and Gynecology, vol. 175, no. 2, pp. 435–441, 1996. View at Google Scholar · View at Scopus
  46. D. A. Eschenbach, S. Hillier, C. Critchlow et al., “Diagnosis and clinical manifestations of bacterial vaginosis,” American Journal of Obstetrics and Gynecology, vol. 158, pp. 819–828, 1988. View at Google Scholar
  47. A. P. Korn, G. Bolan, N. Padian, M. Ohm-Smith, J. Schachter, and D. V. Landers, “Plasma cell endometritis in women with symptomatic bacterial vaginosis,” Obstetrics and Gynecology, vol. 85, no. 3, pp. 387–390, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. J. F. Peipert, A. B. Montagno, A. S. Cooper, and C. J. Sung, “Bacterial vaginosis as a risk factor for upper genital tract infection,” American Journal of Obstetrics and Gynecology, vol. 177, no. 5, pp. 1184–1187, 1997. View at Google Scholar · View at Scopus
  49. A. P. Korn, N. A. Hessol, N. S. Padian et al., “Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis,” American Journal of Obstetrics and Gynecology, vol. 178, no. 5, pp. 987–990, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. R. L. Sweet, “Role of bacterial vaginosis in pelvic inflammatory disease,” Clinical Infectious Diseases, vol. 20, no. 2, pp. S271–S275, 1995. View at Google Scholar · View at Scopus
  51. R. B. Ness, K. E. Kip, S. L. Hillier et al., “A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease,” American Journal of Epidemiology, vol. 162, no. 6, pp. 585–590, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. J. K. Hebb, C. R. Cohen, S. G. Astete, E. A. Bukusi, and P. A. Totten, “Detection of novel organisms associated with salpingitis, by use of 16S rDNA polymerase chain reaction,” Journal of Infectious Diseases, vol. 190, no. 12, pp. 2109–2120, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. L. E. Manhart, C. W. Critchlow, K. K. Holmes et al., “Mucopurulent cervicitis and Mycoplasma genitalium,” Journal of Infectious Diseases, vol. 187, no. 4, pp. 650–657, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. J. Pépin, A.-C. Labbé, N. Khonde et al., “Mycoplasma qenitalium: an organism commonly associated with cervicitis among west African sex workers,” Sexually Transmitted Infections, vol. 81, no. 1, pp. 67–72, 2005. View at Publisher · View at Google Scholar · View at PubMed
  55. B. R. Moller, D. Taylor-Robinson, P. M. Furr, and E. A. Freundt, “Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium,” British Journal of Experimental Pathology, vol. 66, no. 4, pp. 417–426, 1985. View at Google Scholar · View at Scopus
  56. A. Barzynska, P. Funch, J. Fedder, H. J. Knudsen, S. Birkelund, and G. Christiansen, “Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis: In vitro organ culture study,” Human Reproduction, vol. 22, no. 4, pp. 968–979, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. R. L. Sweet and R. S. Gibbs, “Pelvic inflammatory disease,” in Infectious Diseases of the Female Genital Tract, pp. 220–244, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2009. View at Google Scholar
  58. D. L. Patton, Y. T. C. Sweeney, and C. C. Kuo, “Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage,” Journal of Infectious Diseases, vol. 169, no. 3, pp. 680–683, 1994. View at Google Scholar · View at Scopus
  59. R. C. Brunham and R. W. Peeling, “Chlamydia trachomatis antigens: role in immunity and pathogenesis,” Infectious Agents and Disease, vol. 3, no. 5, pp. 218–233, 1994. View at Google Scholar · View at Scopus
  60. L. O. Eckert, S. E. Hawes, P. Wölner-Hanssen et al., “Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease,” Journal of Infectious Diseases, vol. 175, no. 6, pp. 1453–1458, 1997. View at Google Scholar · View at Scopus
  61. R. L. Sweet, J. Schachter, and M. O. Robbie, “Failure of β-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis,” Journal of the American Medical Association, vol. 250, no. 19, pp. 2641–2645, 1983. View at Publisher · View at Google Scholar · View at Scopus
  62. W. R. Crombleholme, J. Schachter, M. Ohm-Smith, J. Luft, R. Whidden, and R. L. Sweet, “Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin,” American Journal of Medicine, vol. 87, no. 5, pp. 142S–147S, 1989. View at Google Scholar · View at Scopus
  63. C. K. Walker, J. G. Kahn, A. E. Washington, H. B. Peterson, and R. L. Sweet, “Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy,” Journal of Infectious Diseases, vol. 168, no. 4, pp. 969–978, 1993. View at Google Scholar · View at Scopus
  64. C. K. Walker and R. L. Sweet, “Management,” in Pelvic Inflammatory Disease, R. L. Sweet and H. C. Wiesenfeld, Eds., pp. 141–156, Taylor & Francis, London, UK, 2006. View at Google Scholar
  65. R. B. Ness, S. L. Hillier, K. E. Kip et al., “Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women,” American Journal of Epidemiology, vol. 161, no. 2, pp. 186–195, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. L. O. Eckert, S. S. Thwin, S. L. Millier, N. B. Kiviat, and D. A. Eschenbach, “The antimicrobial treatment of subacute endometritis: a proof of concept study,” American Journal of Obstetrics and Gynecology, vol. 190, no. 2, pp. 305–313, 2004. View at Publisher · View at Google Scholar · View at PubMed
  67. S. M. Lareau and R. H. Beigi, “Pelvic inflammatory disease and tubo-ovarian abscess,” Infectious Disease Clinics of North America, vol. 22, no. 4, pp. 693–708, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. R. L. Sweet, “Sexually transmitted diseases. Pelvic inflammatory disease and infertility in women,” Infectious Disease Clinics of North America, vol. 1, no. 1, pp. 199–215, 1987. View at Google Scholar · View at Scopus
  69. D. Eschenbach, “Treatment of pelvic inflammatory disease,” Clinical Infectious Diseases, vol. 44, no. 7, pp. 961–963, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. L. Svensson, P. A. Mardh, and L. Westrom, “Infertility after acute salpingitis with special reference to Chlamydia trachomatis,” Fertility and Sterility, vol. 40, no. 3, pp. 322–329, 1983. View at Google Scholar · View at Scopus
  71. S. D. Hillis, R. Joesoef, P. A. Marchbanks, J. N. Wasserheit, W. Cates, and L. Westrom, “Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility,” American Journal of Obstetrics and Gynecology, vol. 168, no. 5, pp. 1503–1509, 1993. View at Google Scholar · View at Scopus
  72. K. J. Smith, R. B. Ness, H. C. Wiesenfeld, and M. S. Roberts, “Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies,” Sexually Transmitted Diseases, vol. 34, no. 12, pp. 960–966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. K. E. Aldridge, D. Ashcraft, K. Cambre, C. L. Pierson, S. G. Jenkins, and J. E. Rosenblatt, “Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 4, pp. 1238–1243, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. R. H. Beigi, M. N. Austin, L. A. Meyn, M. A. Krohn, and S. L. Hillier, “Antimicrobial resistance associated with the treatment of bacterial vaginosis,” American Journal of Obstetrics and Gynecology, vol. 191, no. 4, pp. 1124–1129, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. G. W. Amsden, “Anti-inflammatory effects of macrolides—An underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?” Journal of Antimicrobial Chemotherapy, vol. 55, no. 1, pp. 10–21, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. D. L. Patton, Y. T. Cosgrove Sweeney, and W. E. Stamm, “Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment,” Journal of Infectious Diseases, vol. 192, no. 1, pp. 129–135, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. C. D. Bevan, G. L. Ridgway, and C. D. Rothermel, “Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease,” Journal of International Medical Research, vol. 31, no. 1, pp. 45–54, 2003. View at Google Scholar · View at Scopus
  78. R. B. Ness, G. Trautmann, H. E. Richter et al., “Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial,” Obstetrics and Gynecology, vol. 106, no. 3, pp. 573–580, 2005. View at Google Scholar · View at Scopus
  79. J. A. McGregor, W. R. Crombleholme, E. Newton, R. L. Sweet, R. Tuomala, and R. S. Gibbs, “Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis,” Obstetrics and Gynecology, vol. 83, no. 6, pp. 998–1004, 1994. View at Google Scholar · View at Scopus
  80. R. F. Savaris, L. M. Teixeira, T. G. Torres, M. I. A. Edelweiss, J. Moncada, and J. Schachter, “Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial,” Obstetrics and Gynecology, vol. 110, no. 1, pp. 53–60, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. L. Yip, P. J. Sweeny, and B. F. Bock, “Acute suppurative salpingitis with concomitant intrauterine pregnancy,” American Journal of Emergency Medicine, vol. 11, no. 5, pp. 476–479, 1993. View at Publisher · View at Google Scholar · View at Scopus
  82. A. C. Blanchard, J. G. Pastorek, and T. Weeks, “Pelvic inflammatory disease during pregnancy,” Southern Medical Journal, vol. 80, no. 11, pp. 1363–1365, 1987. View at Google Scholar · View at Scopus
  83. D. L. Hemsel, W. J. Ledger, M. Martens, G. R. G. Monif, N. G. Osborne, and J. L. Thomason, “Concerns regarding the centers for disease control's published guidelines for pelvic inflammatory disease,” Clinical Infectious Diseases, vol. 32, no. 1, pp. 103–107, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. A. P. Korn, D. V. Landers, J. R. Green, and R. L. Sweet, “Pelvic inflammatory disease in human immunodeficiency virus-infected women,” Obstetrics and Gynecology, vol. 82, no. 5, pp. 765–768, 1993. View at Google Scholar · View at Scopus
  85. K. L. Irwin, A. C. Moorman, M. J. O'Sullivan et al., “Influence of human immunodeficiency virus infection on pelvic inflammatory disease,” Obstetrics and Gynecology, vol. 95, no. 4, pp. 525–534, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. C. R. Cohen, “Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study,” Journal of Infectious Diseases, vol. 178, no. 5, pp. 1352–1358, 1998. View at Google Scholar · View at Scopus
  87. E. A. Bukusi, C. R. Cohen, C. E. Stevens et al., “Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy,” American Journal of Obstetrics and Gynecology, vol. 181, no. 6, pp. 1374–1381, 1999. View at Google Scholar
  88. N. R. Mugo, J. A. Kiehlbauch, R. Nguti et al., “Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis,” Obstetrics and Gynecology, vol. 107, no. 4, pp. 807–812, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. G. Soderberg and S. Lindgren, “Influence of an intrauterine device on the course of an acute salpingitis,” Contraception, vol. 24, no. 2, pp. 137–143, 1981. View at Google Scholar · View at Scopus
  90. S. Altunyurt, N. Demir, and C. Posaci, “A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 107, no. 1, pp. 81–84, 2003. View at Publisher · View at Google Scholar
  91. R. Hamasuna, Y. Osada, and J. S. Jensen, “Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5′ nuclease real-time PCR,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 12, pp. 4993–4998, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. P. Horner, B. Thomas, C. B. Gilroy, M. Egger, and D. Taylor-Robinson, “Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis,” Clinical Infectious Diseases, vol. 32, no. 7, pp. 995–1003, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. E. Jernberg, A. Moghaddam, and H. Moi, “Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study,” International Journal of STD and AIDS, vol. 19, no. 10, pp. 676–679, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. C. S. Bradshaw, M. Y. Chen, and C. K. Fairley, “Persistence of Mycoplasma genitalium following azithromycin therapy,” PLoS ONE, vol. 3, no. 11, Article ID e3618, 2008. View at Publisher · View at Google Scholar · View at PubMed